George Blumenschein
-
- Lung Cancer Research Studies 3
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 2
- Cancer Immunotherapy and Biomarkers 2
- Otorhinolaryngology top 10%
- Dermatology top 10%
- Ophthalmology top 10%
-
- Lung Cancer Treatments and Mutations 10
-
- Histone Deacetylase Inhibitors Research 3
-
- Nonmelanoma Skin Cancer Studies 3
- Co-authors
- Bita EsmaeliMonique B. NilssonRoy S. HerbstVassiliki A. PapadimitrakopoulouJohn V. HeymachVíctor G. PrietoAllan LiptonDavid Lee
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
George Blumenschein
19 papers receiving 327 citations
Peers
Comparison fields: 5 of 40
- Oncology 215
- Otorhinolaryngology 29
- Dermatology 50
- Ophthalmology 31
- Cancer Research 47
Countries citing papers authored by George Blumenschein
This map shows the geographic impact of George Blumenschein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Blumenschein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Blumenschein more than expected).
Fields of papers citing papers by George Blumenschein
This network shows the impact of papers produced by George Blumenschein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Blumenschein. The network helps show where George Blumenschein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside George Blumenschein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2020 | 0 | |
| 3 | 2020 | 43 | |
| 4 | 2018 | 4 | |
| 5 | 2016 | 4 | |
| 6 | 2015 | 3 | |
| 7 | 2012 | 4 | |
| 8 | 2011 | 29 | |
| 9 | 2009 | 9 | |
| 10 | 2008 | 60 | |
| 11 | 2008 | 1 | |
| 12 | 2007 | 8 | |
| 13 | 2006 | 71 | |
| 14 | 2004 | 16 | |
| 15 | 2004 | 9 | |
| 16 | 2003 | 2 | |
| 17 | 2002 | 27 | |
| 18 | A marrow harvest procedure under local anesthesia. | 1995 | 3 |
| 19 | Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer. | 1984 | 7 |
| 20 | 1982 | 27 |
About George Blumenschein
George Blumenschein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Toxicology, having authored 20 papers that have together received 336 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (3 papers), Histone Deacetylase Inhibitors Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Nonmelanoma Skin Cancer Studies (3 papers), CAR-T cell therapy research (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (215 citations), Otorhinolaryngology (29 citations) and Dermatology (50 citations). George Blumenschein has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Bita Esmaeli, Monique B. Nilsson, Roy S. Herbst, Vassiliki A. Papadimitrakopoulou, John V. Heymach, Víctor G. Prieto, Allan Lipton, David Lee, Harold A. Harvey and Deborah S. White. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.